Chapter 3. risk versus benefit in medical decision making

被引：0
|
作者：
机构：
来源：
Studies in Health Technology and Informatics | 2011年 / 171卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：39 / 78
相关论文
共 50 条
  • [41] Risk-benefit ratio for surgical sympathectomy: Dilemmas in clinical decision making
    Raja, SN
    Campbell, JN
    JOURNAL OF PAIN, 2000, 1 (04): : 261 - 264
  • [42] Exploring the effect of risk and benefit information provision on vaccination decision-making
    Mostafapour, Mehrnaz
    Meyer, Samantha B.
    Scholer, Abigail
    VACCINE, 2019, 37 (44) : 6750 - 6759
  • [43] Perspectives on benefit-risk decision-making in vaccinology: Conference report
    Greenberg, M.
    Simondon, F.
    Saadatian-Elahi, M.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (01) : 176 - 181
  • [44] Analysis of Benefit-risk Balance in Decision-making of the Food and Drug Administration for Premarket Approval of Therapeutic Medical Devices
    Muragaki, Yoshihiro
    Uematsu, Miyuki
    Iseki, Hiroshi
    Umezu, Mitsuo
    ADVANCED BIOMEDICAL ENGINEERING, 2013, 2 : 101 - 106
  • [45] Risk versus benefit
    Curry, S
    CHEMISTRY & INDUSTRY, 2002, (18) : 16 - +
  • [46] Benefit versus risk
    Rich, RR
    JOURNAL OF IMMUNOLOGY, 2003, 170 (06): : 2793 - 2793
  • [47] Decision making under the EU's social chapter
    Goerke, L
    Piazolo, K
    INTERNATIONAL REVIEW OF LAW AND ECONOMICS, 1998, 18 (02) : 217 - 237
  • [48] Decomposing decision-making in preschoolers: Making decisions under ambiguity versus risk
    Garon, Nancy
    Doucet, Ellen
    Inness, Bronwyn
    PLOS ONE, 2024, 19 (09):
  • [49] MAPPING BENEFIT-RISK DECISION-MAKING PROCESSES AND IDENTIFYING DECISION POINTS WITH THE POTENTIAL TO INCLUDE PATIENT PREFERENCE INFORMATION THROUGHOUT THE MEDICAL PRODUCT LIFECYCLE
    Whichello, C.
    Bywall, Scholin K.
    Mauer, J.
    Watt, S.
    Cleemput, I
    Pinto, C. A.
    van Overbeeke, E.
    Huys, I
    de Bekker-Grob, E. W.
    Hermann, R.
    Veldwijk, J.
    VALUE IN HEALTH, 2018, 21 : S324 - S324
  • [50] Mapping benefit-risk decision-making processes and identifying decision points with the potential to include patient preference information throughout the medical product lifecycle
    Whichello, Chiara
    Bywall, Karin Scholin
    Mauer, Jonathan
    Watt, Stephen J.
    Cleemput, Irina
    Anne, Cathy
    van Overbeeke, Eline
    Huys, Isabelle
    Janssens, Rosanne
    Hermann, Richard
    Veldwijk, Jorien
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 206 - 206
12345